| NDC Code | 50845-0122-1 |
|---|
| Package Description | 30 mL in 1 BOTTLE, DROPPER (50845-0122-1) |
|---|
| Product NDC | 50845-0122 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Teething |
|---|
| Non-Proprietary Name | Aconitum Napellus, Belladonna, Borax, Calcarea Phosphorica, Chamomilla, Kali Phosphoricum, Magnesia Phosphorica, Nitricum Acidum, Staphysagria, |
|---|
| Dosage Form | LIQUID |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20110125 |
|---|
| End Marketing Date | 20220412 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Liddell Laboratories, Inc. |
|---|
| Substance Name | ACONITUM NAPELLUS; ATROPA BELLADONNA; CHAMOMILE; DELPHINIUM STAPHISAGRIA SEED; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; NITRIC ACID; POTASSIUM PHOSPHATE, DIBASIC; SODIUM BORATE; TRIBASIC CALCIUM PHOSPHATE |
|---|
| Strength | 30; 30; 3; 9; 8; 30; 6; 30; 8 |
|---|
| Strength Unit | [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL |
|---|
| Pharmacy Classes | Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
|---|